07.01.04
NutraGenesis, Brattleboro, VT, has received its second U.S. patent, No. 6,713,092, for Sensoril™, which is a proprietary anti-stress nutraceutical marketed exclusively by the company as a bulk ingredient. The patent covers both the composition and method for obtaining the composition for pharmaceutical, nutritional and personal care applications. Sensoril is derived from the Ayurvedic herb Ashwagandha. The patented extraction process and the composition it yields provides a new and improved extract, which contains all the desired bioactives in optimized concentrations and ratios in order to provide optimal health and anti-stress benefits associated with Ashwagandha, according to the company. Sensoril contains a minimum of 8% withanolides, the known actives, which are responsible for the reputed anti-stress properties of the plant.